For Korean stock market news & analysis, Click Here

[Mar 10, 2026] US News & Featured Stocks - Mid-morning Report (11:00 AM)

Mar 10, 2026: Nvidia prepares "NemoClaw" open-source platform; Nio shocks with Q4 profit; Oracle clarifies OpenAI data center progress;

 


[Market Pulse: The "War & Oil" Seesaw]

  • Geopolitical Fog: President Trump signaled that military goals are near completion and the war could end "very soon." Conversely, Defense Secretary Hegseth warned today would see the "strongest strikes yet" on Iran.

  • Oil Retreat: WTI dropped to approximately $87/bbl, giving back recent gains. G7 energy ministers are meeting in Paris to discuss strategic reserve releases.

  • Crypto: Bitcoin surged past $70,000, showing resilience amid macro uncertainty.



[Tech & AI Infrastructure]

■ Nvidia (NVDA): Introducing "NemoClaw"

  • Open Source Agent: Nvidia is reportedly preparing NemoClaw, an open-source AI agent platform. Collaborations with Salesforce, Cisco, and Adobe are underway for pilot testing.

  • GTC Anticipation: BofA maintained a Buy ($300 TP) ahead of next week’s GTC Conference. Expectations include a preview of the Feynman architecture (planned for 2028) and details on the Rubin GPU production ramp-up.

  • Valuation: Trading at a forward P/E of 17x (historical lows), Nvidia remains a top valuation pick given its growth profile.

■ Meta Platforms (META): Engagement Goldmine

  • Usage Surge: Citizens noted that global time spent on Meta apps is up 17% YoY over the last 7 months, far outpacing user growth (6%).

  • Upgrades: Erste Group upgraded Meta to Buy, while Moody's maintained an Aa3 credit rating, citing revenue growth expectations of 20%+ in 2026.

■ Oracle (ORCL): OpenAI Project Status

  • Data Center Clarity: Despite rumors of a breakdown in Texas, reports confirm the 8-site deal with OpenAI is proceeding. OpenAI is relocating additional capacity to other states, including Wisconsin, with 6+ sites in development.

  • Earnings Watch: Analysts expect EPS of $1.70 and Revenue of $16.92B in the report due after today's close.

■ TSMC (TSM): AI Demand Offsets Seasonality

  • Revenue Growth: Jan-Feb revenue hit $22.6B, up 30% YoY. Massive capex from Google and Amazon (totaling $650B+ in 2026) continues to feed the TSMC foundry engine.


[Semiconductors & Equipment]

■ Applied Materials (AMAT) & Micron (MU): Announced a major partnership to develop next-gen AI memory (DRAM/HBM) at Applied’s EPIC Center and Micron's Boise facility. 

■ Lam Research (LRCX) & AMAT: Morgan Stanley highlighted "unprecedented" demand visibility, with major customers already booking equipment for 2027 installations.


[Earnings & Corporate Highlights]

■ Nio (NIO): The Ultimate Surprise

  • Profit Switch: Reported a surprise Q4 net profit of $40.4M, shattering analyst expectations of a loss.

  • Efficiency: Revenue grew 76% YoY, while R&D spending was slashed by 19%. Q1 delivery guidance ($80k–83k units) is also above Wall Street estimates.

■ HP Enterprise (HPE): Beat Q1 EPS ($0.65 vs. $0.58) and issued strong Q2 revenue guidance ($9.6B–$10.0B), signaling robust enterprise AI demand. 

■ GE Vernova (GEV): Extended a nuclear fuel supply contract with Entergy through 2035, introducing the next-gen GNF4 fuel design. 

■ Casey's General Stores (CASY): Significant EPS beat ($3.49 vs. $2.98) driven by strong fuel margins ($0.41/gallon).


[Healthcare & Biotech]

■ Vertex Pharmaceuticals (VRTX): Met primary goals in Phase 3 trials for Povetacicep (IgA nephropathy). FDA accelerated approval filing is expected by month-end. TP: $530 (Evercore ISI)

■ BioNTech (BNTX): Shares pressured after a larger-than-expected Q4 loss and weak 2026 guidance. Founders Ugur Sahin and Ozlem Tureci are set to depart by year-end. 

■ Novo Nordisk (NVO): Downgraded to Hold by TD Cowen. Concerns focus on the lack of a non-Semaglutide pipeline to offset patent cliffs starting in some regions this month.


[Analyst Moves & Others]

■ MicroStrategy (MSTR): Initiated with Buy ($175 TP) at B. Riley. The company now holds 3.4% of the world's Bitcoin supply. 

■ Chipotle (CMG): Stifel maintained Buy ($45 TP), noting that new automated kitchen equipment is boosting same-store sales by 2% in early-adopter locations. 

■ Jefferies (JEF): Downgraded to Neutral at Morgan Stanley due to legal risks involving Western Alliance Bank and exposure to a bankrupt UK mortgage lender. 

■ Kinetik (KNTK): Highlighted as a top Permian midstream play with a 7.1% dividend yield and high M&A potential.



In Be Stock. Expert U.S. market news, trending stock analysis, and essential investor education. The best way to stay in the best stocks.

Post a Comment

New comments are not allowed.